City

Bloomington (1)

Brussels (1)

New Orleans (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 4 (1)

Sponsor

Indiana University (1)

Louisiana State University Health Sciences Center in New Orleans (1)

Sciensano (1)

Collaborator

Jessa Hospital (1)

Merck Sharp & Dohme LLC (1)

Intervention

human papillomavirus 9-valent vaccine, recombinant (1)

immediate vs. delayed provision of antibody test results (1)

Study Documents

Intervention Type

behavioral (1)

biological (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

serology

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection Trial in New Orleans (Human papillomavirus

Not yet recruiting

Papillomavirus Vaccines
+6 more

Human papillomavirus 9-valent vaccine, recombinant

New Orleans, Louisiana

University Medical Center New Orleans

Mar 3, 2022

SARS-CoV-2, Serology, Students Trial in Bloomington (Immediate vs. delayed provision of antibody test results)

Completed

Has Results

SARS-CoV-2
+2 more

Immediate vs. delayed provision of antibody test results

Bloomington, Indiana

Indiana University

Jan 27, 2022

COVID-19, Serology Trial in Brussels

Completed

COVID-19
Serology

Brussels, Belgium

Sciensano

Sep 4, 2020